Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Farahnik

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Dermatological Treatment|August 30, 2016
Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a reviewMio Nakamura, Kristina Lee, Rasnik Singh, et al.
Journal of the American Academy of Dermatology|October 18, 2016
Interventional treatments for Hailey-Hailey diseaseBenjamin Farahnik, Collin M Blattner, Michael B Mortazie, et al.
Dermatology and Therapy|February 25, 2016
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Tian Hao Zhu, et al.
American Journal of Clinical Dermatology|March 4, 2016
The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation InjuryTian Hao Zhu, Mio Nakamura, Benjamin Farahnik, et al.
Dermatology and Therapy|May 26, 2016
Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Michael Abrouk, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptabilityMichael Abrouk, Ethan Levin, Merrick Brodsky, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Anti-IL-17 Agents for Psoriasis: A Review of Phase III DataBenjamin Farahnik, Kourosh Beroukhim, Mio Nakamura, et al.
Dermatology Online Journal|May 25, 2017
Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case reportBenjamin Farahnik, Kourosh Beroukhim, Mio Nakamura, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptabilityBenjamin Farahnik, Viraat Patel, Kourosh Beroukhim, et al.
Psoriasis (Auckland, N.Z.)|September 1, 2017
Erythrodermic psoriasis: pathophysiology and current treatment perspectivesRasnik K Singh, Kristina M Lee, Derya Ucmak, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Dermatological Treatment|August 30, 2016
Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a reviewMio Nakamura, Kristina Lee, Rasnik Singh, et al.
Journal of the American Academy of Dermatology|October 18, 2016
Interventional treatments for Hailey-Hailey diseaseBenjamin Farahnik, Collin M Blattner, Michael B Mortazie, et al.
Dermatology and Therapy|February 25, 2016
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Tian Hao Zhu, et al.
American Journal of Clinical Dermatology|March 4, 2016
The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation InjuryTian Hao Zhu, Mio Nakamura, Benjamin Farahnik, et al.
Dermatology and Therapy|May 26, 2016
Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsBenjamin Farahnik, Kourosh Beroukhim, Michael Abrouk, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptabilityMichael Abrouk, Ethan Levin, Merrick Brodsky, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Anti-IL-17 Agents for Psoriasis: A Review of Phase III DataBenjamin Farahnik, Kourosh Beroukhim, Mio Nakamura, et al.
Dermatology Online Journal|May 25, 2017
Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case reportBenjamin Farahnik, Kourosh Beroukhim, Mio Nakamura, et al.
Psoriasis (Auckland, N.Z.)|February 2, 2018
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptabilityBenjamin Farahnik, Viraat Patel, Kourosh Beroukhim, et al.
Psoriasis (Auckland, N.Z.)|September 1, 2017
Erythrodermic psoriasis: pathophysiology and current treatment perspectivesRasnik K Singh, Kristina M Lee, Derya Ucmak, et al.
Pageof 3